Provided by Tiger Trade Technology Pte. Ltd.

Guardant Health Inc.

91.17
+3.574.08%
Post-market: 90.70-0.4700-0.52%16:47 EDT
Volume:1.43M
Turnover:129.10M
Market Cap:12.09B
PE:-27.46
High:92.19
Open:87.08
Low:87.08
Close:87.60
52wk High:120.74
52wk Low:36.36
Shares:132.57M
Float Shares:127.00M
Volume Ratio:0.68
T/O Rate:1.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3203
EPS(LYR):-3.3203
ROE:-4584.47%
ROA:-15.59%
PB:-121.71
PE(LYR):-27.46

Loading ...

Earning Preview: Guardant Health Inc. this quarter’s revenue is expected to increase by 46.86%, and institutional views are bullish

Earnings Agent
·
Apr 30

Guardant Health receives FDA approval for Guardant360 CDx

TIPRANKS
·
Yesterday

FDA approves Guardant360 CDx as companion diagnostic for Pfizer-Arvinas VEPPANU

Reuters
·
Yesterday

Guardant Health Receives FDA Approval for Guardant360® Cdx as a Companion Diagnostic for Arvinas and Pfizer’s Veppanu (Vepdegestrant) for Patients With Er+/Her2- Advanced Breast Cancer With Esr1 Mutations

THOMSON REUTERS
·
Yesterday

Guardant falls after FDA panel votes down AstraZeneca breast cancer drug

TIPRANKS
·
May 01

Guardant Health partners with Nuvalent on companion diagnostics development, commercialization support

Reuters
·
Apr 30

Guardant Health Announces Multi-Year Strategic Collaboration With Nuvalent to Develop Companion Diagnostics and Support Potential Commercialization of Targeted Cancer Therapies Using the Guardant Infinity™ Platform

THOMSON REUTERS
·
Apr 30

Guardant Health to present at BofA Securities 2026 Healthcare Conference fireside chat

Reuters
·
Apr 30

Guggenheim Keeps Their Buy Rating on Guardant Health (GH)

TIPRANKS
·
Apr 29

GH Research Announces Pricing of $117.5 Million Underwritten Offering

GlobeNewswire
·
Apr 29

Guardant Health announces annual shareholder meeting

Reuters
·
Apr 29

Guardant falls after FDA briefing documents for camizestrant

TIPRANKS
·
Apr 29

H.C. Wainwright Reaffirms Their Buy Rating on GH Research (GHRS)

TIPRANKS
·
Apr 29

Analysts Have Conflicting Sentiments on These Healthcare Companies: Phathom Pharmaceuticals (PHAT), Pfizer (PFE) and Guardant Health (GH)

TIPRANKS
·
Apr 28

Guardant Health Says Chief Medical Officer to Resign

MT Newswires Live
·
Apr 28

Guardant Health Chief Medical Officer Craig Eagle resigns, effective May 8

Reuters
·
Apr 28

H.C. Wainwright Keeps Their Buy Rating on GH Research (GHRS)

TIPRANKS
·
Apr 21

GH Research Up Nearly 22%, on Track for Highest Close Since January 2022 -- Data Talk

Dow Jones
·
Apr 20

GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness

GlobeNewswire
·
Apr 20

Guardant Health director Tariq Musa sells 116 shares worth $9,840.28

Reuters
·
Apr 17